Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

StARD7 Inhibitors

StARD7 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the StARD7 protein, a member of the START (StAR-related lipid transfer) domain family. StARD7 plays a crucial role in intracellular lipid transport, particularly in the movement of phospholipids between cellular membranes. It is primarily involved in transferring phosphatidylcholine, an essential phospholipid component of cellular membranes, from the endoplasmic reticulum to the mitochondria. This lipid transfer is essential for maintaining mitochondrial membrane integrity and function, as phospholipids are crucial for the structural and functional properties of membranes. By facilitating lipid transport, StARD7 ensures that mitochondria have the necessary lipid components to support energy production, signaling, and other vital cellular processes. Inhibitors of StARD7 disrupt this lipid transport mechanism, potentially leading to imbalances in lipid distribution and altered membrane composition.

The mechanism of action of StARD7 inhibitors typically involves binding to the START domain of the protein, preventing it from interacting with phospholipid molecules or impairing its ability to facilitate their transfer between membranes. Some inhibitors may compete with lipid substrates for binding to the START domain, while others might induce conformational changes that reduce StARD7's lipid-binding affinity or transport capacity. By inhibiting StARD7, these compounds can lead to disruptions in mitochondrial lipid homeostasis, affecting mitochondrial structure, membrane fluidity, and overall cellular energy metabolism. Research into StARD7 inhibitors provides valuable insights into the role of lipid transfer proteins in cellular function and highlights the significance of phospholipid distribution in maintaining organelle integrity. Understanding how StARD7 regulates lipid trafficking between cellular compartments helps illuminate the broader importance of lipid metabolism in cellular homeostasis and membrane dynamics.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Miltefosine

58066-85-6sc-203135
50 mg
$81.00
8
(1)

Interferes with phospholipid metabolism and can disrupt mitochondrial membrane phospholipids.

rac Perhexiline Maleate

6724-53-4sc-460183
10 mg
$188.00
(0)

Modulates lipid metabolism and can affect mitochondrial function by altering lipid availability.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

Influences phospholipid metabolism and can disrupt mitochondrial membranes.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$31.00
$89.00
$135.00
$443.00
13
(1)

Inhibits HMG-CoA reductase, potentially altering lipid biosynthesis and mitochondrial function.

Fenofibrate

49562-28-9sc-204751
5 g
$41.00
9
(1)

Activates PPARα, which can lead to changes in lipid metabolism affecting mitochondrial lipids.

(+)-Etomoxir sodium salt

828934-41-4sc-215009
sc-215009A
5 mg
25 mg
$151.00
$506.00
3
(2)

Inhibits carnitine palmitoyltransferase-1, potentially influencing mitochondrial lipid uptake.

Bisphenol A

80-05-7sc-391751
sc-391751A
100 mg
10 g
$300.00
$490.00
5
(0)

May disrupt cellular signaling and lipid homeostasis, affecting mitochondrial function.

Valinomycin

2001-95-8sc-200991
25 mg
$250.00
3
(1)

Forms ion channels in mitochondrial membranes, possibly disrupting membrane potential.

Oligomycin A

579-13-5sc-201551
sc-201551A
sc-201551B
sc-201551C
sc-201551D
5 mg
25 mg
100 mg
500 mg
1 g
$179.00
$612.00
$1203.00
$5202.00
$9364.00
26
(1)

Inhibits ATP synthase, leading to altered mitochondrial energetics and lipid metabolism.

Cerulenin (synthetic)

17397-89-6sc-200827
sc-200827A
sc-200827B
5 mg
10 mg
50 mg
$161.00
$312.00
$1210.00
9
(1)

Inhibits fatty acid synthase, possibly affecting lipid composition of mitochondria.